Biolife Solutions (BLFS) Return on Capital Employed (2011 - 2026)
Biolife Solutions (BLFS) posted quarterly Return on Capital Employed of 3.99% for Q1 2026, down 353.0% year-over-year from 1.58% in Q1 2025, and up 5.61% quarter-over-quarter from 4.22% in Q4 2025.
Biolife Solutions (BLFS) Return on Capital Employed (2011 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Return on Capital Employed for 16 consecutive years, with 3.99% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 353.0% year-over-year to 3.99%; the TTM figure through Mar 2026 stood at 3.99% (down 353.0% YoY), while the FY2025 annual figure was 4.37%, down 317.0% from the prior year.
- Return on Capital Employed improved to 3.99% in Q1 2026 per BLFS's latest filing, from 4.22% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 13.59% in Q2 2023 and bottomed at 26.14% in Q3 2022.
- Historically, Return on Capital Employed has averaged 3.62% across 5 years, with a median of 3.22% in 2024.
- Annual changes were most pronounced in 2022 — Return on Capital Employed tumbled 2176 bps — and 2023, when it surged 3948 bps.
- Biolife Solutions' Return on Capital Employed stood at 1.4% in 2022, then plunged by 330 bps to 6.0% in 2023, then jumped by 79 bps to 1.25% in 2024, then sank by 238 bps to 4.22% in 2025, then rose by 6 bps to 3.99% in 2026.
- Business Quant data shows BLFS's Return on Capital Employed at 3.99% in Q1 2026, 4.22% in Q4 2025, and 4.6% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | 0.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.73% |
| Mar 31, 2026 | -3.99% |
| Dec 31, 2025 | -4.22% |
| Sep 30, 2025 | -4.60% |
| Jun 30, 2025 | -4.69% |
| Mar 31, 2025 | -0.45% |
| Dec 31, 2024 | -1.25% |
| Sep 30, 2024 | 3.61% |
| Jun 30, 2024 | -0.71% |
| Mar 31, 2024 | -3.22% |
| Dec 31, 2023 | -6.00% |
| Sep 30, 2023 | 13.34% |
| Jun 30, 2023 | 13.59% |
| Mar 31, 2023 | -2.88% |
| Dec 31, 2022 | -1.40% |
| Sep 30, 2022 | -26.14% |
| Jun 30, 2022 | -24.23% |
| Mar 31, 2022 | -8.24% |
| Dec 31, 2021 | -6.84% |
| Sep 30, 2021 | -4.38% |